000 | 01353 a2200373 4500 | ||
---|---|---|---|
005 | 20250515011321.0 | ||
264 | 0 | _c20060511 | |
008 | 200605s 0 0 eng d | ||
022 | _a0168-8278 | ||
024 | 7 |
_a10.1016/j.jhep.2005.11.012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSulkowski, Mark S | |
245 | 0 | 0 |
_aTreatment algorithm for the management of hepatitis C in HIV-coinfected persons. _h[electronic resource] |
260 |
_bJournal of hepatology _c2006 |
||
300 |
_aS49-55 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAlgorithms |
650 | 0 | 4 |
_aAnti-Retroviral Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 | _aDrug Carriers |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 |
_aHepatitis C _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInterferon alpha-2 |
650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
650 | 0 | 4 |
_aPolyethylene Glycols _xtherapeutic use |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 |
_aRibavirin _xtherapeutic use |
650 | 0 | 4 | _aTreatment Outcome |
773 | 0 |
_tJournal of hepatology _gvol. 44 _gno. 1 Suppl _gp. S49-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jhep.2005.11.012 _zAvailable from publisher's website |
999 |
_c15980300 _d15980300 |